You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 29, 2025

Details for Patent: 6,149,940


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,149,940
Title: Tablet with controlled release of alfuzosine chlorhydrate
Abstract:Pharmaceutical tablet which consists of: a) a first layer having the property of swelling considerably and quickly on contact with aqueous biological fluids, the first layer being produced by compression of a mixture or of a granulate comprising hydrophilic polymers, and b) a second layer adjacent to the first layer being formulated with hydrophilic polymers and with other auxiliary substances in order to give the preparation suitable properties of compressibility and in order to allow the release of alfuzosin hydrochloride within a predetermined time period.
Inventor(s): Maggi; Lauretta (Pavia, IT), Conte; Ubaldo (Busto Arisizio., IT), Grenier; Pascal (Saint Louis, FR), Vergnault; Guy (Saint Louis, FR), Dufour; Alain (Paris, FR), Jarreau; Fran.cedilla.ois Xavier (Versailles, FR), Rauch-Desanti; Clemence (Ozoire la Ferriere, FR)
Assignee: Synthelabo (Le Plessis-Robinson, FR) Jagotec AB (Hergiswil, CH)
Application Number:09/147,581
Patent Claim Types:
see list of patent claims
Compound; Dosage form; Composition;
Patent landscape, scope, and claims:

United States Patent 6,149,940: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 6,149,940, titled "Tablet with controlled release of alfuzosin hydrochloride," is a significant patent in the pharmaceutical field, particularly in the area of controlled-release drug delivery systems. This patent, now expired, was granted to address specific challenges in the administration of alfuzosin hydrochloride, a medication used to treat benign prostatic hyperplasia.

Patent Overview

Invention Description

The patent describes a pharmaceutical tablet designed to release alfuzosin hydrochloride in a controlled manner. The tablet consists of two or three layers, each with specific functions:

  • Layer 1: Contains the active substance.
  • Layer 2: Acts as a barrier to modify the release of the active substance.
  • Layer 3: Composed of hydrophilic polymers that gel and/or swell upon contact with gastric juices, further controlling the release rate[4].

Production Process

The tablets are produced using standard tableting processes, including the use of rotary presses capable of producing multi-layer tablets. The layers are formed by mixing powders and/or granulates and compressing them into the desired shape[4].

Patent Claims

Independent Claims

The patent includes several independent claims that define the scope of the invention. These claims typically focus on the structure and composition of the tablet, including the specific layers and their functions. For example:

  • Claim 1 might describe the overall structure of the tablet with its multiple layers.
  • Claim 2 could detail the composition of each layer, including the types of polymers used[4].

Dependent Claims

Dependent claims further specify the invention by adding additional details to the independent claims. These might include:

  • The specific amounts of each layer.
  • The method of producing the tablets.
  • The shape and size of the tablets[4].

Patent Scope

Metrics for Measuring Patent Scope

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics help in understanding the breadth and clarity of the patent claims. For instance, narrower claims are often associated with a higher probability of grant and a shorter examination process[3].

Application to US 6,149,940

In the case of US 6,149,940, the patent claims are relatively specific, focusing on the unique multi-layer structure and the controlled release mechanism. This specificity suggests that the patent scope is well-defined, reducing the likelihood of overly broad claims that could lead to litigation and licensing issues.

Inventorship and Conception

Determining True and Only Inventors

US patent law emphasizes the importance of identifying the true and only inventors, which is crucial for the validity and enforceability of the patent. The conception step, where the idea is formed in the mind of the inventor, is a critical aspect of determining inventorship. For US 6,149,940, the inventors would have had to conceive the idea of the multi-layer tablet with controlled release of alfuzosin hydrochloride and reduce it to practice[2].

Patent Landscape

Global Dossier and International Integration

The patent landscape for pharmaceutical inventions like US 6,149,940 is influenced by global initiatives such as the Global Dossier, which provides access to file histories of related applications from participating IP Offices. This integration helps in understanding the global patent family and citation data, which can be crucial for navigating the complex landscape of pharmaceutical patents[1].

Public Search Facilities and Resources

Resources like the USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) are essential for conducting thorough patent searches. These facilities provide access to patent and trademark information, helping inventors and patent attorneys to ensure that their inventions are novel and non-obvious[1].

Legal and Litigation Aspects

Court Decisions and Patent Validity

The validity of patents can be challenged in court, and decisions from courts like the Court of Appeals for the Federal Circuit are pivotal in shaping patent law. For instance, the court's decisions on inventorship and claim construction can impact the enforceability of patents like US 6,149,940[2][5].

Examples and Illustrations

Production and Administration

The patent includes detailed descriptions of how the tablets are produced and administered. For example, the tablets are designed to increase in volume upon contact with gastric juices, which can be monitored using video microscopy. This detailed description helps in understanding the practical application of the invention[4].

Statistics and Industry Impact

Pharmaceutical Industry Trends

The pharmaceutical industry has seen significant advancements in controlled-release drug delivery systems. Patents like US 6,149,940 contribute to these advancements by providing innovative solutions to drug administration challenges. Statistics on patent filings and grants in this area can indicate the level of innovation and competition within the industry.

Expert Insights

Quotes from Industry Experts

Industry experts often highlight the importance of well-defined patent claims and the need for thorough searches to ensure novelty and non-obviousness. For example:

"The clarity and specificity of patent claims are crucial for avoiding litigation and ensuring the enforceability of the patent"[3].

Key Takeaways

  • Specific Claims: The patent includes specific claims that define the structure and composition of the multi-layer tablet.
  • Controlled Release: The invention focuses on a controlled release mechanism for alfuzosin hydrochloride.
  • Production Process: The tablets are produced using standard tableting processes.
  • Global Integration: The patent landscape is influenced by global initiatives like the Global Dossier.
  • Legal Considerations: The validity and enforceability of the patent depend on correct inventorship and claim construction.

FAQs

What is the main innovation of US 6,149,940?

The main innovation is the design of a multi-layer tablet that provides controlled release of alfuzosin hydrochloride.

How are the tablets produced?

The tablets are produced using rotary presses and standard tableting processes, involving the compression of powders and/or granulates into the desired shape.

Why is correct inventorship important?

Correct inventorship is crucial for the validity and enforceability of the patent, ensuring that only the true and only inventors are listed.

What resources are available for patent searches?

Resources include the USPTO Public Search Facility, Patent and Trademark Resource Centers (PTRCs), and online tools like the Global Dossier.

How does the patent landscape impact pharmaceutical inventions?

The patent landscape, influenced by global initiatives and court decisions, affects the novelty, non-obviousness, and enforceability of pharmaceutical patents.

Cited Sources

  1. USPTO: Search for patents - USPTO.
  2. Oregon State University: Determining Inventorship for US Patent Applications.
  3. SSRN: Patent Claims and Patent Scope.
  4. Google Patents: Tablet with controlled release of alfuzosin hydrochloride.
  5. United States Court of Appeals for the Federal Circuit: DDR Holdings.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,149,940

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 6,149,940

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France96 10551Aug 29, 1996
France97 04386Apr 10, 1997
PCT Information
PCT FiledAugust 22, 1997PCT Application Number:PCT/FR97/01515
PCT Publication Date:March 05, 1998PCT Publication Number: WO98/08515

International Family Members for US Patent 6,149,940

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
African Regional IP Organization (ARIPO) 1107 ⤷  Try for Free
African Regional IP Organization (ARIPO) 9901470 ⤷  Try for Free
Argentina 009312 ⤷  Try for Free
Australia 4020197 ⤷  Try for Free
Australia 724490 ⤷  Try for Free
Austria 200864 ⤷  Try for Free
Bulgaria 103138 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 7 of 7 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.